POSTER SESSION II
Monday, March 9, 2009 — 1:00 PM - 4:30 PM
Hynes CC - Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
28
The Role of IGF1R and PTEN/Akt Pathway in Young Patients with Breast Carcinoma According to Immunophenotypes
(273)
M Planelles, FI Aranda, E Alcaraz, M Niveiro, J Segui, G Peiro - University General Hospital of Alicante, Alicante, Spain
PI3K/Akt/mTOR Pathway in HER2-positive Invasive Breast Carcinoma. An Immunohistochemical and Molecular Analysis
(270)
G Peiro, L Sanchez-Tejada, E Lerma, FI Aranda, J Sanchez-Paya, E Adrover - Hospital General Universitari, Alacant, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Invasive Micropapillary Breast Carcinoma Is a Lymphotropic Entity That Belongs to the Luminal Group. A Phenotypic, Chromogenic In Situ Hybridization and Retrospective Study of 164 Cases
(125)
F Bibeau, H Frugier, F Mishellany, G M Grogan, M Lacroix-Triki, F Penault-Llorca, M Antoine, V Becette, P Berteau, F Boissiere-Michot - CRLC Val d'Aurelle, Montpellier, France; Centre Jean Perrin, Clermont-Ferrand, France; Institut Bergonie, Bordeaux, France; Institut Claudius Regaud, Toulouse, France; Hopital Tenon, Paris, France; Centre Rene Huguenin, Saint-Cloud, France; Hopital Saint-Louis, Paris, France
Transcriptomic Profiling of Early Metastatic Transition in Breast Carcinomas
(167)
PL Fernandez, J Calvo, L Gelabert, M Marin, JJ Lozano, R Bermudo, TM Thomson - Hospital Clinic/IDIBAPS, University of Barcelona, Barcelona, Spain; Instituto de Biología Molecular, CSIC, Barcelona, Spain; Hospital Clinic/IDIBAPS, Barcelona, Spain
Aberrant WT-1 Expression in Myoepithelial Cells of Inflammatory Breast Cancer
(315)
TN Vinh, W Wang, JS Ni, YG Man - Armed Forces Institute of Pathology and American Registry of Pathology, Washington, DC; China-Japan-Frinedship Hospital, Changchun, Jilin, China; Norman Bethune College of Medical Science, Changchun, Jilin, China
Comparison of Breast Cancers in Hispanic and Non-Hispanic Caucasian Women Using Array Comparative Genomic Hybridization
(328)
I Yeh, K Beedupalli, T Lu, SR Gunn, RS Robetorye - University of Texas Health Science Center at San Antonio, San Antonio, TX; Combimatrix Molecular Diagnostics, Irvine, CA
Polycomb Transcription Factor Bmi-1 Expression Is Associated with Favorable Outcome in Mammary Carcinoma
(282)
JS Ross, E Slodkowska, CE Sheehan - Albany Medical College, Albany, NY
Reduced Expression of Fanconi Anemia Complementation Group F 4 Is Associated with an Aggressive Phenotype and Shortened Survivial in Breast Cancer
(301)
EA Slodkowska, AB Boguniewicz, CE Sheehan, JS Ross - Albany Medical College, Albany, NY
Molecular Profiling of Grade III Invasive Ductal Breast Cancers Identifies PPM1D Amplification as a Therapeutic Target in Luminal and HER2 Tumours
(255)
R Natrajan, SM Rodriguez-Pinilla, MBK Lambros, DSP Tan, C Marchio, R Vatcheva, S Rayter, G Moreno-Bueno, LG Fulford, A Mackay, A Grigoriadis, K Fenwick, N Tamber, D Hardisson, A Tutt, J Palacios, H Buerger, CJ Lord, A Ashworth, JS Reis-Filho - ICR, London, United Kingdom; CNIO, Madrid, Spain; Instituto de Investigaciones Biomedicas Alberto Sols, Madrid, Spain; The Ludwig Institute for Cancer Research, London, United Kingdom; Hospital Universitario La Paz, Madrid, Spain; Hospital Virgen del Rocio, Seville, Spain; Institute of Pathology, Paderborn, Germany
Expression of CD44+/CD24- Cells in Breast Cancer
(238)
XQ Lu, ZH Suo, CL Ma, KJ Xu, YS Liu, HX Li - Zhengzhou University School of Medicine, Zhengzhou, Henan, China; Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
Loss of Caveolin - 1 Expression in Breast Cancer Associated Fibroblasts Correlates with Tumor Aggressiveness
(325)
AK Witkiewicz, A Dasgupta, F Sotgia, M Sabel, CG Kleer, M Lisanti - Thomas Jefferson University, Philadelphia, PA; Kimmel Cancer Center and Thomas Jefferson - University, Philadelphia, PA; University of Michigan Medical School, Ann Arbor, MI
Genomic Profiling of Mitochondria-Rich Breast Cancer
(277)
JS Reis-Filho, D de Biase, MBK Lambros, FC Geyer, M Ragazzi, R Natrajan, A Mackay, N Tamber, K Fenwick, A Ashworth, G Tallini, V Eusebi - ICR, London, United Kingdom; University of Bologna, Bologna, Italy
Expression of the Epithelial Mesenchymal Transition Regulator Snail in Matrix-Producing Carcinomas of the Breast
(187)
K Gwin, A Contreras, M Tretiakova, A Montag - University of Chicago Medical Center, Chicago, IL
A Glimpse into Tumor Metabolism by Magnetic Resonance Spectroscopy: Choline Compounds and Choline Kinase Gene Expression in Human Breast Cancer
(196)
SD Herberger, D Kaul, CB Adkins, BL Smith, LL Cheng, MR Lentz, EF Brachtel - Massachusetts General Hospital, Boston, MA
Aberrant Expression, and Potency as Cancer Markers/Targets, of Splicing Regulators in Breast Cancer
(227)
M Lacroix-Triki, JF Dupuy, F Dalenc, S Dejean, P Besse, H Roche, P Rochaix, S Vagner - Institute Claudius Regaud, Toulouse, France; Institut de Mathematiques de Toulouse, Toulouse, France
Differential Pattern of Methylation within Hormone Receptor Negative Breast Cancers
(137)
D Chitale, A Botrell, KM Chen, L Whiteley, L Neimier, Z Zhang, G Divine, U Raju, MJ Worsham - Henry Ford Hospital, Detroit, MI
Expression of Phospho(p)STAT3 and Phospho(p)STAT5 in Breast Cancer and Correlation with Plasma Prolactin Levels
(121)
NA Belsley, LC Collins, MS Rice, S Walker, S Tworoger, DA Frank - Beth Israel Deaconess Medical Center, Boston; Harvard Medical School, Boston; Channing Institute, Boston; Dana-Farber Cancer Institute, Boston, MA
"Molecular Apocrine" Breast Carcinomas Develop Brain Metastases Early with Respect to the Appearance of Systemic Metastases
(303)
X Song, K Hengel, AS Braverman, G Sidhu, YD Kim, J Weedon, X Li, CA Axiotis - Kings County Medical Center, Brooklyn, NY; SUNY Downstate Medical Center, Brooklyn, NY; Case Western Reserve University, Cleveland, OH
The Novel Estrogen-Induced Gene EIG121 Is Up-Regulated in Estrogen Receptor Positive Breast Cancer, Significantly Associated with Recurrence Free and Overall Survival, and Is Associated with Sensitivity to Tamoxifen
(154)
L Deng, B Hennessy, R Broaddus - M.D. Anderson Cancer Center, Houston, TX
Multivariate Analysis of Immunohistochemical Data from 6925 Breast Cancer Patients: Molecular Classification Using 6 Well Known Markers
(297)
HP Sinn, S Aulmann, P Schirmacher - University Hospital Heidelberg, Heidelberg, Germany
Differential Localization of EZRIN Expression in Normal and Neoplastic Mammary Tissue
(133)
C-H Chen, JA Chapman, A Rajput, H Mak, A Perry, H Feilotter, S SenGupta, BE Elliott - Queen's University, Kingston, ON, Canada; Cancer Research Institute, Kingston, ON, Canada
Cofilin Expression in Breast Carcinoma with Hormone Receptor-Positive: Prognostic Significance
(110)
F Aranda, J Segui, L Sanchez-Tejada, M Niveiro, J Laforga, C Alenda, M Planelles, G Peiro - Universitary General Hospital, Alicante, Spain; General Hospital, Denia, Alicante, Spain
Molecular Profile of Breast Cancer Metastases to the Central Nervous System
(105)
N Alberti, D Val, J Vicens, MF Garijo, JF Val-Bernal, P de Agustin, MJ Merino - National Cancer Institute, Bethesda, MD; Marques de Valdecilla University Hospital, Santander, Spain; "12 de Octubre" University Hospital, Madrid, Spain
Caracterisation of Breast Cancer Diagnosed during Pregnancy or during the Three Years after Delivery by Tissue Array
(109)
M Antoine, B Lesieur, A Rodenas, P Callard, S Uzan, R Rouzier - TENON Hospital, Paris, France; Universite Pierre et Marie Curie, Paris, France
Significance of C-Kit Expression in Breast Ductal Carcinoma
(120)
D Bautista, ML Bernal, A Jimenez, I Arranz, S Luna - Hospital Carlos Haya, Malaga, Spain; DG Innovacion Sanitaria, Sistemas y Tecnologias, Sevilla, Spain
D2-40 Reactivity in Spindle Cell Lesions of the Breast
(170)
MT Galgano, KA Atkins, MR Wick, SE Mills - Univ. of Virginia Health System, Charlottesville, VA
Expression of IMP3 in Primary and Metastatic Breast Ductal Adenocarcinomas
(200)
MC Hure, Z Jiang, D Lu - University of Massachusetts Medical Center, Worcester, MA
Cell Signalling Factors in Breast Tumors. Tumor Cell Distribution May Define Tumors with Different Oncogenic Pathways Activated. The Critical Role of the Pathologist in Its Evaluation
(269)
V Peg, B Pons, MA Vazquez, EA Martinez, T Moline, O Cordoba, JL Lirola, S Ramon y Cajal - H.U.Vall Hebron, Barcelona, Spain; H.U. Vall Hebron, Barcelona, Spain
A Role for the AHR, an Environmental Pollutant Activated Receptor and Transcription Factor, in Mammary Tumor Progression
(249)
S Narasimhan, DH Sherr - Boston University School of Medicine and Boston University School of Public Health, Boston, MA
The Role of Adipocytes in Mammary Carcinoma Microenvironment
(217)
JY Kim, FA Tavassoli - Pusan National University School of Medicine, Busan, Korea; Yale University School of Medicine, New Haven, CT
Altered Histone Modifications and Their Regulating Enzymes in Fulvestrant Resistant Breast Cancer Cell Line In Vitro
(162)
SE Elsheikh, AR Green, RA McClelland, IR Hutcheson, JM Gee, RI Nicholson, IO Ellis - School of Molecular Medical Science, Nottingham University, Nottingham, United Kingdom; Welsh School of Pharmacy, Cardiff University, Cardiff, United Kingdom
Conditional Deletion of the LKB1 Gene in the Mouse Mammary Gland Induces Tumour Formation
(244)
A McCarthy, CJ Lord, K Savage, A Grigoriadis, DP Smith, B Weigelt, JS Reis-Filho, A Ashworth - ICR, London; Ludwig Institute for Cancer Research, London, UK; Ludwig Institute for Cancer Research, Melbourne, Australia; Lawrence Berkeley National Laboratory, Berkeley
Mammary Intraductal Foam Cells Are Bone Marrow Derived and Are Recruited in Response to Both Physiological as Well as Neoplastic Stimuli
(119)
SH Barsky, Y Xiao, Y Ye, K Yearsley -The Ohio State University College of Medicine, Columbus, OH
A 19-Gene Classifier Distinguishes Invasive Ductal and Classic Lobular Breast Carcinomas: Amplification of Chromosome 8q Characterizes Ductal While Estrogen-Related EGR-1 Characterizes Lobular Cancers
(149)
AC Culhane, A Nasir, DT Chen, C Venkataramu, J White, T Andersson, M Gruidl, G Bloom, R Rubio, BA Centeno, J Quackenbush, TJ Yeatman - Dana-Farber Cancer Institute, Boston, MA; Moffitt Cancer Center, Tampa, FL
button next to any title to add to Itinerary Planner...
Add
